Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection

Mem Inst Oswaldo Cruz. 2009 Dec;104(8):1083-90. doi: 10.1590/s0074-02762009000800004.

Abstract

Gap junction connexin-43 (Cx43) molecules are responsible for electrical impulse conduction in the heart and are affected by transforming growth factor-beta (TGF-beta). This cytokine increases during Trypanosoma cruzi infection, modulating fibrosis and the parasite cell cycle. We studied Cx43 expression in cardiomyocytes exposed or not to TGF-beta T. cruzi, or SB-431542, an inhibitor of TGF-beta receptor type I (ALK-5). Cx43 expression was also examined in hearts with dilated cardiopathy from chronic Chagas disease patients, in which TGF-beta signalling had been shown previously to be highly activated. We demonstrated that TGF-beta treatment induced disorganised gap junctions in non-infected cardiomyocytes, leading to a punctate, diffuse and non-uniform Cx43 staining. A similar pattern was detected in T. cruzi-infected cardiomyocytes concomitant with high TGF-beta secretion. Both results were reversed if the cells were incubated with SB-431542. Similar tests were performed using human chronic chagasic patients and we confirmed a down-regulation of Cx43 expression, an altered distribution of plaques in the heart and a significant reduction in the number and length of Cx43 plaques, which correlated negatively with cardiomegaly. We conclude that elevated TGF-beta levels during T. cruzi infection promote heart fibrosis and disorganise gap junctions, possibly contributing to abnormal impulse conduction and arrhythmia that characterise severe cardiopathy in Chagas disease.

MeSH terms

  • Adult
  • Animals
  • Benzamides / therapeutic use*
  • Chagas Disease / drug therapy
  • Chagas Disease / metabolism*
  • Connexin 43 / metabolism*
  • Dioxoles / therapeutic use*
  • Female
  • Fluorescent Antibody Technique
  • Gap Junctions / drug effects
  • Gap Junctions / metabolism*
  • Humans
  • Immunohistochemistry
  • Male
  • Mice
  • Microscopy, Confocal
  • Middle Aged
  • Myocytes, Cardiac / chemistry*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Receptors, Transforming Growth Factor beta / antagonists & inhibitors*
  • Transforming Growth Factor beta / therapeutic use*

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Benzamides
  • Connexin 43
  • Dioxoles
  • Receptors, Transforming Growth Factor beta
  • Transforming Growth Factor beta